Artiva Biotherapeutics, Inc.
ARTV- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001817241
In the last 90 days, Artiva Biotherapeutics, Inc. insiders filed 5 open-market purchases and 7 sales; 72 institutions reported holding it in 13F filings for Q2 2026, worth $391.6M in total; Viking Global Investors is the only superinvestor holding it.
13F holders, Q4 2025
Institutional positions in Artiva Biotherapeutics, Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 34
- −6 vs. Q3 2025
- Shares held
- 17.0M
- −1.20M (−6.6%) vs. Q3 2025
- Total value
- $72.7M
- +$20.6M (+39.6%) vs. Q3 2025
- New holders
- 6
- 4 more added
- Sold out
- 12
- 15 more reduced
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ARTV on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 72 | $391.6M |
| Q1 2026 | 40 | $108.4M |
| Q4 2025 | 34 | $72.7M |
| Q3 2025 | 40 | $52.1M |
| Q2 2025 | 48 | $27.9M |
| Q1 2025 | 53 | $62.8M |
| Q4 2024 | 57 | $213.2M |
| Q3 2024 | 49 | $319.4M |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding Artiva Biotherapeutics, Inc.; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Advisor Group Holdings, Inc. | 32 | $137 | 0.00% | +32 | New |
| Bank of America Corp | 113 | $484 | 0.00% | −16,032−99.3% | Reduced |
| JPMorgan Chase & Co | 187 | $802 | 0.00% | −3,815−95.3% | Reduced |
| Royal Bank of Canada | 339 | $1.00K | 0.00% | −501−59.6% | Reduced |
| Mark Sheptoff Financial Planning, LLC | 400 | $1.72K | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 542 | $2.33K | 0.00% | −118,005−99.5% | Reduced |
| Tower Research Capital LLC (TRC) | 1,103 | $4.73K | 0.00% | −8,878−88.9% | Reduced |
| Wells Fargo & Company | 1,500 | $6.43K | 0.00% | −200−11.8% | Reduced |
| FMR LLC | 3,558 | $15.3K | 0.00% | −1,362−27.7% | Reduced |
| Russell Investments Group, Ltd. | 5,491 | $23.6K | 0.00% | 00.0% | Unchanged |
| Prelude Capital Management, LLC | 10,691 | $45.9K | 0.00% | −3,611−25.2% | Reduced |
| Goldman Sachs Group Inc | 12,060 | $51.7K | 0.00% | −37,717−75.8% | Reduced |
| Omers Administration Corp | 21,100 | $90.5K | 0.00% | +21,100 | New |
| Morgan Stanley | 27,072 | $116.1K | 0.00% | −15,757−36.8% | Reduced |
| Scientech Research LLC | 27,757 | $119.1K | 0.07% | +27,757 | New |
| Bridgeway Capital Management, LLC | 35,000 | $150.2K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 35,824 | $153.7K | 0.00% | −24,000−40.1% | Reduced |
| UBS Group AG | 36,873 | $158.2K | 0.00% | +15,730+74.4% | Added |
| Jane Street Group, LLC | 40,671 | $174.5K | 0.00% | +40,671 | New |
| Marshall Wace, LLP | 79,559 | $341.3K | 0.00% | +79,559 | New |
| Alyeska Investment Group, L.P. | 100,000 | $429.0K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 101,117 | $434.1K | 0.00% | −9,779−8.8% | Reduced |
| Renaissance Technologies LLC | 116,200 | $498.5K | 0.00% | +37,053+46.8% | Added |
| Two Sigma Investments, LP | 144,864 | $621.5K | 0.00% | +124,500+611.4% | Added |
| Wellington Management Group LLP | 194,108 | $832.7K | 0.00% | 00.0% | Unchanged |
| BlackRock, Inc. | 212,538 | $911.8K | 0.00% | −81,884−27.8% | Reduced |
| Millennium Management LLC | 217,097 | $931.3K | 0.00% | −45,063−17.2% | Reduced |
| Vanguard Group Inc | 246,006 | $1.06M | 0.00% | +86,888+54.6% | Added |
| Revelation Capital Management, LLC | 299,311 | $1.28M | 1.54% | +299,311 | New |
| Franklin Resources Inc | 520,327 | $2.23M | 0.00% | 00.0% | Unchanged |
| venBio Partners LLC | 648,507 | $2.78M | 1.29% | −500,468−43.6% | Reduced |
| VR Adviser, LLC | 1,609,569 | $6.91M | 0.34% | 00.0% | Unchanged |
| 5AM Venture Management, LLC | 2,353,304 | $10.1M | 3.17% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 9,853,302 | $42.3M | 0.43% | 00.0% | Unchanged |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −798,397−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −105,573−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −47,973−100.0% | Sold out |
| Landscape Capital Management, L.L.C. | 0 | $0 | 0.00% | −39,133−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −26,953−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −25,552−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −12,696−100.0% | Sold out |
| China Universal Asset Management Co., Ltd. | 0 | $0 | 0.00% | −4,281−100.0% | Sold out |
| Mirae Asset Global Investments Co., Ltd. | 0 | $0 | 0.00% | −944−100.0% | Sold out |
| GF Fund Management Co. Ltd. | 0 | $0 | 0.00% | −510−100.0% | Sold out |
| EverSource Wealth Advisors, LLC | 0 | $0 | 0.00% | −159−100.0% | Sold out |
| Cloud Capital Management, LLC | 0 | $0 | 0.00% | −11−100.0% | Sold out |